Jubilant Ingrevia Limited Bombay S.E.

543271

INE0BY001018

Specialty Chemicals

Market Closed - Bombay S.E. Other stock markets 06:15:42 2024-04-19 am EDT			5-day change	1st Jan Change
538 ^INR	+1.72%		-2.50%	+6.02%

Apr. 17	Jubilant Ingrevia Issues Commercial Papers Worth INR1 Billion	MT
Apr. 01	Jubilant Ingrevia Limited Commissions New Facility for Diketenes & Derivatives	CI

Jubilant Ingrevia Limited Intimates Repayment of Commercial Paper

November 02, 2022 at 05:59 am EDT

Jubilant Ingrevia Limited announced that Commercial Papers of INR 500 million, bearing ISIN INE0BY014094, issued on August 30, 2022, has been fully redeemed by the Company on October 28, 2022 i.e. the maturity date.

Latest news about Jubilant Ingrevia Limited

Jubilant Ingrevia Issues Commercial Papers Worth INR1 Billion	Apr. 17	MT
Jubilant Ingrevia Limited Commissions New Facility for Diketenes & Derivatives	Mar. 31	CI
Jubilant Ingrevia Fully Redeems INR500 Million Commercial Paper at Maturity	Mar. 27	MT
Jubilant Ingrevia, O2 Renewable Tie Up for Green Energy Generation; Shares Drop 4%	Mar. 12	MT
Jubilant Ingrevia Commissions Multi-Purpose Agro Active and Intermediate Plant in Gujarat, India	Mar. 05	MT
Transcript : Jubilant Ingrevia Limited, Q3 2024 Earnings Call, Jan 30, 2024	Jan. 30
Jubilant Ingrevia Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 30	CI
Jubilant Ingrevia Limited Approves Interim Dividend for the Financial Year 2023-24, Payable on or Before February 28, 2024	Jan. 30	CI
Jubilant Ingrevia Limited Commissions Mutipurpose Agro Intermediate Plant for Value Added Derivatives	Dec. 30	CI
Jubilant Ingrevia Redeems INR1 Billion Commercial Paper at Maturity	Dec. 27	MT
Jubilant Ingrevia Redeems INR1 Billion at Maturity Date	Nov. 15	MT
Jubilant Ingrevia Raises INR1 Billion from Commercial Papers	Nov. 09	MT
Transcript : Jubilant Ingrevia Limited, Q2 2024 Earnings Call, Nov 01, 2023	Nov. 01
Jubilant Ingrevia Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 01	CI
Jubilant Ingrevia Limited Announces Change in Management	23-10-27	CI
Jubilant Ingrevia Raises INR1 Billion from Commercial Paper Issue	23-10-26	MT
Jubilant Ingrevia Raises INR2 Billion Via Issue of Commerical Papers	23-09-10	MT
Jubilant Ingrevia Names Managing Director-CEO	23-09-01	MT
Jubilant Ingrevia Limited Approves Final Dividend for the Financial Year Ended March 31, 2023	23-09-01	CI
Jubilant Ingrevia Limited Approves Appointment of Deepak Jain as CEO, Effective October 1, 2023	23-09-01	CI
Jubilant Ingrevia Limited Approves Appointment of Deepak Jain as Director and Managing Director, Effective October 1, 2023	23-09-01	CI
Jubilant Ingrevia Gets Board Nod to Raise Up To INR6 Billion Via Issue of Commercial Paper	23-08-18	MT
Transcript : Jubilant Ingrevia Limited, Q1 2024 Earnings Call, Jul 27, 2023	23-07-27
Jubilant Ingrevia Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-07-26	CI
Jubilant Ingrevia Raises INR1.25 Billion Via Issue of Commercial Papers	23-07-25	MT

Chart Jubilant Ingrevia Limited

Duration

Period

More charts

Company Profile

Jubilant Ingrevia Limited is an India-based integrated provider of life sciences products and solutions. The Company's segments include Speciality Chemicals, Nutrition and Health Solutions, and Chemical Intermediates. The Speciality Chemicals segment includes pyridine and picolines, fine chemicals, agro chemicals, and custom development and manufacturing organization. The Nutrition and Health Solutions segment includes nutrition and health ingredients, and animal and human nutrition health solutions. The Chemical Intermediates segment includes acetyls and speciality ethanol. Its agro chemicals business is focused on agro intermediates and agro actives, including insecticides, herbicides and fungicides. Its range of products includes nutritional ingredients, such as vitamin B3, vitamin B4, picolinates and premix formulations for both animal and human nutrition. The Company serves various industries, such as pharmaceutical, nutrition, agrochemical, consumer and industrial customers.

Sector

Specialty Chemicals

Calendar

2024-05-13 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Jubilant Ingrevia Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

537.8 INR

Average target price

557.3 INR

Spread / Average Target

+3.62%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
ECOLAB INC.	+9.99%	62.67B
SIKA AG	-6.50%	45.97B
GIVAUDAN SA	+13.40%	39.51B
FUJIFILM HOLDINGS CORPORATION	+17.90%	26.04B
EMS-CHEMIE HOLDING AG	+1.03%	17.71B
CELANESE CORPORATION	-0.59%	17.25B
SYMRISE AG	+5.78%	15.44B
POSCO FUTURE M CO., LTD.	-29.39%	14.54B
ALBEMARLE CORPORATION	-22.38%	13.14B

Other Specialty Chemicals

Jubilant Ingrevia Limited Bombay S.E.

Equities

543271

INE0BY001018

Specialty Chemicals

Jubilant Ingrevia Limited Intimates Repayment of Commercial Paper

EPS Revisions